Medical devices, healthcare technology and the business of care
510(k) clearance · K262420

Maverix Cryo Biopsy Pro (MCB Pro) (MCBP-1000); Maverix Cryo Cartridge (CC-1000)

Serpex Medical · Decision date Sep 2, 2026

MEDTECHLEDGER EXPLANATIONK262420

What did the FDA decide?

Serpex Medical received a substantially equivalent (SESE) decision for K262420 on September 2, 2026, covering the Maverix Cryo Biopsy Pro (MCB Pro) probe (MCBP-1000) and the Maverix Cryo Cartridge (CC-1000). The submission was received July 16, 2026, and reviewed under 21 CFR 878.4350 as a Class II cryosurgical unit and accessory, product code GEH, in the General and Plastic Surgery panel. A SESE decision is a 510(k) clearance, not a PMA approval.

The system pairs a sterile, single-use flexible cryoprobe with a non-sterile, single-use nitrous oxide cartridge; the cartridge is loaded by a non-sterile assistant and suspended outside the sterile field while the probe's distal end stays within it. The summary names the ERBECRYO 2 cryosurgical unit and Erbe flexible cryoprobes (K190651, cleared January 7, 2020) as predicate, with differences in refrigerant gas, gas delivery, sheath-adjustable working length and a pointed, sheathed tip. The source does not include performance testing results or the full indications comparison.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262420
Regulatory pathway
510(k) premarket notification
Product code
GEH
Decision code
SESE
Decision date
Sep 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Unit, Cryosurgical, Accessories.

Product code
GEH
FDA device class
2

FDA decision timeline

  1. K262420 received

    Application receipt date recorded by FDA.

  2. K262420 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GEH

Product / regulatory recordCompanyPathwayDecision dateSource
Cryoconcepts LP510(k) clearanceOct 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Serpex Medical

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Santa Clara, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records